Segment Information (Tables)

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Summary of Segment Information

The following table summarizes the segment information (in thousands):

	Three Months Ended March 31,
	2020		2019
Net revenues:
Clinical Services	$	92,982	$	86,210
Pharma Services	13,048		9,367
Total revenue	106,030		95,577
Cost of revenue:
Clinical Services	48,923		42,651
Pharma Services	10,738		5,811
Total cost of revenue	59,661		48,462
Gross Profit:
Clinical Services	44,059		43,559
Pharma Services	2,310		3,556
Total gross profit	46,369		47,115
Operating expenses:
General and administrative	36,344		32,142
Research and development	2,060		1,209
Sales and marketing	13,258		11,216
Total operating expenses	51,662		44,567
(Loss) income from operations	(5,293)		2,548
Interest expense, net	819		1,826
Other (income) expense	(223)		5,169
Loss before taxes	(5,889)		(4,447)
Income tax expense (benefit)	1,089		(2,023)
Net loss	$	(6,978)	$	(2,424)